Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 1, pp. 105949-105949
Open Access | Times Cited: 4850

Showing 51-75 of 4850 citing articles:

Clinical management of COVID-19
George M. Varghese, Rebecca John, Abi Manesh, et al.
The Indian Journal of Medical Research (2020) Vol. 151, Iss. 5, pp. 401-401
Open Access | Times Cited: 504
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Ioannis Zabetakis, Ronan Lordan, Catherine Norton, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1466-1466
Open Access | Times Cited: 500
Convalescent plasma in Covid-19: Possible mechanisms of action
Manuel Rojas, Yhojan Rodríguez, Diana M. Monsalve, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102554-102554
Open Access | Times Cited: 492
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
Awadhesh Kumar Singh, Akriti Singh, Altamash Shaikh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 3, pp. 241-246
Open Access | Times Cited: 490
Immunopathology of Hyperinflammation in COVID-19
Joshua Gustine, Dennis Jones
American Journal Of Pathology (2020) Vol. 191, Iss. 1, pp. 4-17
Open Access | Times Cited: 480
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
Abdurrahman Tufan, Aslıhan Avanoğlu Güler, Marco Matucci‐Cerinic
TURKISH JOURNAL OF MEDICAL SCIENCES (2020) Vol. 50, Iss. SI-1, pp. 620-632
Open Access | Times Cited: 479
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Matthieu Million, Jean‐Christophe Lagier, Philippe Gautret, et al.
Travel Medicine and Infectious Disease (2020) Vol. 35, pp. 101738-101738
Open Access | Times Cited: 479
Organ-specific manifestations of COVID-19 infection
Maria Gavriatopoulou, Eleni Korompoki, Despina Fotiou, et al.
Clinical and Experimental Medicine (2020) Vol. 20, Iss. 4, pp. 493-506
Open Access | Times Cited: 470
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
Tobias Boettler, Philip N. Newsome, Mario U. Mondelli, et al.
JHEP Reports (2020) Vol. 2, Iss. 3, pp. 100113-100113
Open Access | Times Cited: 467
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement
Oren K. Fix, Bilal Hameed, Robert J. Fontana, et al.
Hepatology (2020) Vol. 72, Iss. 1, pp. 287-304
Open Access | Times Cited: 460
Drug repurposing approach to fight COVID-19
Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 6, pp. 1479-1508
Open Access | Times Cited: 452
In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
Abhigyan Choudhury, Suprabhat Mukherjee
Journal of Medical Virology (2020) Vol. 92, Iss. 10, pp. 2105-2113
Open Access | Times Cited: 451
The hallmarks of COVID-19 disease
Daolin Tang, Paul B. Comish, Rui Kang
PLoS Pathogens (2020) Vol. 16, Iss. 5, pp. e1008536-e1008536
Open Access | Times Cited: 449
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development
Miao-Miao Zhao, Weili Yang, Fangyuan Yang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 447
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Matthieu Mahévas, Viet-Thi Tran, Mathilde Roumier, et al.
BMJ (2020), pp. m1844-m1844
Open Access | Times Cited: 438
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Henning Ulrich, Micheli Mainardi Pillat
Stem Cell Reviews and Reports (2020) Vol. 16, Iss. 3, pp. 434-440
Open Access | Times Cited: 434
Immune response in COVID-19: A review
Mohammad Asaduzzaman Chowdhury, Nayem Hossain, Mohammod Abul Kashem, et al.
Journal of Infection and Public Health (2020) Vol. 13, Iss. 11, pp. 1619-1629
Open Access | Times Cited: 432
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Joydeb Majumder, Tamara Minko
The AAPS Journal (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 430
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Shivraj Hariram Nile, Arti Nile, Jiayin Qiu, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 66-70
Open Access | Times Cited: 423
Clinical trials on drug repositioning for COVID-19 treatment
Sandro G. Viveiros-Rosa, Wilson C. Santos
Revista Panamericana de Salud Pública (2020) Vol. 44, pp. 1-1
Open Access | Times Cited: 422
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
Rebecca H. Haberman, Jordan E. Axelrad, Alan Chen, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 1, pp. 85-88
Open Access | Times Cited: 412
Chloroquine and hydroxychloroquine in covid-19
R E Ferner, Jeffrey K Aronson
BMJ (2020), pp. m1432-m1432
Open Access | Times Cited: 408
COVID-19 and the elderly: insights into pathogenesis and clinical decision-making
Fabio Perrotta, Graziamaria Corbi, Grazia Mazzeo, et al.
Aging Clinical and Experimental Research (2020) Vol. 32, Iss. 8, pp. 1599-1608
Open Access | Times Cited: 403
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
Wesley H. Self, Matthew W. Semler, Lindsay Leither, et al.
JAMA (2020) Vol. 324, Iss. 21, pp. 2165-2165
Open Access | Times Cited: 401
COVID-19 in solid organ transplant recipients: A single-center case series from Spain
Mario Fernández‐Ruiz, Amado Andrés, Carmelo Loinaz, et al.
American Journal of Transplantation (2020) Vol. 20, Iss. 7, pp. 1849-1858
Open Access | Times Cited: 400

Scroll to top